INTRODUCTION {#ss1}
============

Cryopreservation of reproductive cells and tissues is one of the most important parts of biomedical and agricultural researches, which can be used to overcome an infertility of human beings and to preserve valuable genetic resources of endangered and transgenic animals. One of the powerful methods to cryopreserve reproductive cells with decreased cryoinjuries is ultra-rapid freezing method such as vitrification. Recently, a vitrification method has been applied widely to cryopreserve the cells in the mammalian species, including pig ([@bib21]), cattle ([@bib14]), mice ([@bib23]), and human ([@bib6]). Especially in pig oocyte, it is well known that the oocytes matured *in vitro* are very difficult to cryopreserve because of its higher sensitivity to cryoinjuries compared to other mammalian oocytes like human ([@bib13]), cattle ([@bib17]), and small rodent ([@bib11]).

According to our previous report, lipid content, quality, size, and shape of oocytes were responsible for cryotolerance ([@bib18]). In pig, limited studies have been demonstrated a successful vitrification using immature and *in vitro* matured oocytes ([@bib30]; [@bib1]). Vitrification of *in vitro*-matured oocytes might be occur various kinds of cryoinjuries caused by high concentration of cryoprotectant (CPA) in the vitrification medium ([@bib18]). Exposure of oocyte to CPA has been shown to induce cryoinjuries such as microtubule depolymerization and premature exocytosis of cortical granules resulting decreased survival rates and developmental failure ([@bib8]; [@bib24]). The CPA exposed oocytes during vitrification had been changed not only distribution and function of mitochondria but also mitochondrial ultrastructure ([@bib32]; [@bib9]). An abnormal distribution and dysfunction of mitochondria in oocytes were closely involved in the activation of apoptotic mechanisms resulting oocyte dead ([@bib32]). Therefore, vitrification method for pig oocyte is still required to be improved much in survival, fertilization, and developmental rates ([@bib27]; [@bib31]).

To improve survival rates of vitrified oocytes, it is essentially needed a modification of vitrification procedures, development of vitrification devices, and treatment of chemicals during a vitrification procedure. Many chemicals were applied during recovery culture such as signal pathway inhibitors, antioxidants, and cytoskeletal stabilizers ([@bib17]; [@bib19]; [@bib29]). One of the common cytoskeletal stabilizers is cytochalasin B (CB) widely applied for softening of oocyte before conducting micromanipulation such as somatic cell nuclear transfer because of its safety on oocytes ([@bib20]). Chemical treatments during post-warming culture after vitrification can be one of the possible approaches to help oocyte to regain its ability to develop. Therefore, the present study was conducted to determine optimal treatment timing of CB during vitrification and warming procedures.

MATERIALS & METHODS {#ss2}
===================

1.. Experimental design {#ss2_1}
-----------------------

In experiment 1, the survival rates of the post-warming pig oocytes were analyzed by fluorescein diacetate (FDA) assays with 4 classifications as shown in [Fig. 1](#f1){ref-type="fig"}. After vitrification/warming and recovery culture, the pig oocytes were stained with FDA and analyzed its survival rates. The oocytes with strong and intermediate green fluorescence were determined as alive, but weak and none signals were classified as dead. In experiment 2, CB was treated before (CB-Vitri) and after (Vitri-CB) vitrification. Then, the survival rates of post-warming oocytes were analyzed by morphology and FDA assay to determine an appropriate timing and effect of CB treatment.

![**Categorization of viable post-warming pig oocytes by FDA assay.** Oocytes with strong and intermediate signal were determined as alive oocyte while weak and none signal were determined as dead oocyte. FDA, fluorescein diacetate.](dr-22-3-245-g1){#f1}

2.. *In vitro* maturation oocytes {#ss2_2}
---------------------------------

All chemicals were purchased from Sigma-Aldrich Chemicals (St. Louis, MO, USA) unless stated otherwise. Prepubertal pig ovaries were obtained from local slaughterhouse Nonghyup Moguchon, Gimje, Korea) and transported to the laboratory within thermos containing 30℃ to 35℃ of saline. Then, 3--6 mm follicles were aspirated by disposable syringe with an 18 gauge needle and cumulus oocytes complexes (COCs) with several compact layer of cumulus cells were selected for *in vitro* maturation. The COCs were cultured in the hepes-buffered Tissue Culture Medium (TCM)-199 (Gibco BRL, NY, USA) supplemented with 10% porcine follicular fluid (pFF), 3.05 mM D-glucose, 0.57 mM cysteine, 0.91 mM sodium pyruvate, 0.5 μg/mL FSH, 0.5 μg/mL LH, 10 ng/mL EGF, 75 μg/mL penicillin G and 50 μg/mL streptomycin in a four-well dish for 22 h at 38.5℃ under 5% CO~2~ in air. Then the oocytes were matured *in vitro* within the maturation medium described above without FSH and LH for additional 22 h at 38.5℃ under 5% CO~2~ in air. After *in vitro* maturation, the oocytes were examined comprehensively for the extrusion of the first polar body after removal of cumulus cells by treatment of 0.1% hyaluronidase solution with gentle pipetting.

3.. Vitrification and warming of oocytes {#ss2_3}
----------------------------------------

The matured oocytes were conducted to a vitrification and warming according to the method described previously ([@bib17]). Briefly, the oocytes were equilibrated in the base medium \[TCM-199 with 20% fetal bovine serum (FBS, Gibco BRL)\], supplemented with 7.5% ethylene glycol (EG), and 7.5% dimethyl sulfoxide (DMSO) for 5 min. Then, the equilibrated oocytes were transferred into the vitrification solution consisting of 20% FBS, 15% EG, 15% DMSO, and 0.5 M sucrose for 1 min at room temperature. During that time, around 15 oocytes were mounted onto the tip of the Cryotop (Kitazato BioPharma, Shizuoka, Japan) with a minimal volume of the vitrification solution (\< 0.1 μL) and then quickly plunged into liquid nitrogen (LN~2~). After storage for more than 1 week in the LN~2~, the vitrified oocytes were warmed by soaking the tip of the Cryotop into the pre-warmed base medium containing 1 M sucrose at 38.5℃ for 1 min. Then, the oocytes were transferred into the base medium containing 0.5, 0.25, and 0 M sucrose (for 3, 5, and 5 min, respectively) at room temperature (25.0℃). The predicted freezing and warming rates of the Cryotop method informed by the manufacturer were -23,000 and 42,000℃ /min, respectively.

4.. Recovery culture and treatment of cytochalasin B {#ss2_4}
----------------------------------------------------

After vitrification and warming, the oocytes were washed 3 times and conducted to recovery culture with TCM-199 with 5% FBS, 0.2 mM sodium pyruvate, 75 μg/mL penicillin G, and 50 μg/mL streptomycin in a 4-well dish for 2 h at 38.5℃ under 5% CO~2~ in air (30 oocytes per well). The CB was treated before (CB-Vitri) vitrification procedure for 30 minutes and after (Vitri-CB) vitrification procedure from start of recovery culture for 30 minutes with concentration of 7.5 μg/mL.

5.. Analysis of post-warming survival rates {#ss2_5}
-------------------------------------------

The survival of post-warming oocytes was evaluated based on our previous study ([@bib17]). Briefly, the survival was estimated by morphological changes on oolemma and zona pellucida firstly. Demarcation of membrane, zona pellucida fracture, and cytoplasmic distribution were comprehensively checked by microscope. Then, the survival rates based on esterase enzyme activity by FDA assay was assessed. After recovery culture with or without CB, the oocytes were washed 3 times in PBS for 1 min, followed by incubation with 2.5 mg/mL of FDA for 1 min. Then, the oocytes were washed 3 times again in PBS containing 0.1% BSA and observed under an epifluorescence microscope (Leica Microsystems, Wetzlar, Germany). As shown in [Fig. 1](#f1){ref-type="fig"}, the alive oocytes showed strong and intermediate green fluorescence, whereas the dead oocytes showed a weak or none fluorescent signals.

6.. Statistical analysis {#ss2_6}
------------------------

All experiments were replicated at least 4 times in each group. All data were analyzed by Origin 8 software (OriginLab Corporation, Northampton, MA, USA) by applying one-way analysis of variance with arcsine transformation. A value of *p*\<0.05 was considered to be significant.

RESULTS {#ss3}
=======

1.. Survival rates of post-warming pig oocytes {#ss3_1}
----------------------------------------------

According to the results indicated in the [Table 1](#t1){ref-type="table"}, the post-warming oocytes showed significantly decreased the number of the alive compared to the fresh control (31.8% vs. 86.4%) (*p*\<0.05). In detail, the significant difference (*p*\<0.05) was found only in strong fluorescence (18.2% vs. 70.5%), but not in intermediate fluorescence groups (13.6% vs. 15.9%). On the other hand, the number of the dead oocytes were significantly increased (68.2% vs. 13.6%) compared to fresh control (*p*\<0.05). The rates of the dead oocytes in both weak (40.9% vs. 13.6%) and none (27.3% vs. 0.0%) fluorescence groups were significantly different compared to the fresh control (*p*\<0.05), respectively.

###### Survival rates of post-warming pig oocytes examined by FDA assay

  Groups          No. of oocytes examined   No. of oocytes determined as[\*](#t1n1){ref-type="table-fn"}                                                                                                                                                                                       
  --------------- ------------------------- -------------------------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------
  Fresh control   44                        31 (70.5)[^a^](#t1n2){ref-type="table-fn"}                     7 (15.9) [^a^](#t1n2){ref-type="table-fn"}   38 (86.4)[^a^](#t1n2){ref-type="table-fn"}   6(13.6)[^a^](#t1n2){ref-type="table-fn"}     0 (0.0)[^a^](#t1n2){ref-type="table-fn"}     6 (13.6)[^a^](#t1n2){ref-type="table-fn"}
  Post-warming    44                        8 (18.2)[^b^](#t1n2){ref-type="table-fn"}                      6 (13.6)[^a^](#t1n2){ref-type="table-fn"}    14 (31.8)[^b^](#t1n2){ref-type="table-fn"}   18 (40.9)[^b^](#t1n2){ref-type="table-fn"}   12 (27.3)[^b^](#t1n2){ref-type="table-fn"}   30 (68.2)[^b^](#t1n2){ref-type="table-fn"}

Data are represented as total number (mean) of four replicates in each group.

Different superscripts denote significance within columns (*p*\<0.05).

FDA, fluorescein diacetate.

2.. Effect of CB treatment timing on vitrified-warmed pig oocytes {#ss3_2}
-----------------------------------------------------------------

Pig oocytes were treated with CB before and after vitrification procedures to determine appropriate treatment timing for the improvement of survival rates in the post-worming oocytes. After recovery culture, all the vitrified oocytes were subjected to test its viability by morphological inspection and FDA assay. As shown in [Table 2](#t2){ref-type="table"}, the Vitri-CB group showed significantly higher survival rates (91.6% vs. 83.7%) in morphological inspection compared to the CB-Vitri group (*p*\<0.05), respectively, but lower than that of the Fresh Control (100.0%) (*p*\<0.05). Interestingly, the CD-Vitri group showed comparably lower survival rate than that of Vitri-Control (88.7%). According to the results of FDA assay, the Vitri-CB group showed significantly higher (44.2%) survival rates compared to CB-Vitri (36.7%) and Vitri-Control (35.1%) groups (*p*\<0.05), respectively.

###### Effect of Cytochalasin B on viability of post-warming pig oocytes

  Groups          No. of oocytes examined   No. of survived oocytes analyzed by (%)[\*](#t2n1){ref-type="table-fn"}   
  --------------- ------------------------- ------------------------------------------------------------------------- ------------------------------------------------
  Fresh control   57                        57 (100±0.0)[^a^](#t2n2){ref-type="table-fn"}                             48 (84.2±1.6)[^a^](#t2n2){ref-type="table-fn"}
  Vitri-control   97                        86 (88.7±2.8)[^bc^](#t2n2){ref-type="table-fn"}                           34 (35.1±1.5)[^c^](#t2n2){ref-type="table-fn"}
  CB-Vitri        98                        81 (83.7±2.6)[^c^](#t2n2){ref-type="table-fn"}                            36 (36.7±1.6)[^c^](#t2n2){ref-type="table-fn"}
  Vitri-CB        95                        95 (91.6±2.6)[^b^](#t2n2){ref-type="table-fn"}                            42 (44.2±1.0)[^b^](#t2n2){ref-type="table-fn"}

Data are represented as total number (mean±SEM) of four replicates in each group.

Different superscripts denote significance within columns (*p*\<0.05).

FDA, fluorescein diacetate; Vitri-Control, vitrification only; CB-Vitri, CB treatment before vitrification/warming; Vitri-CB, CB treatment after vitrification/warming.

DISCUSSION {#ss4}
==========

Morphological inspection of an oocyte quality and viability by assessment of morphological changes on oolemma and zona pellucida is widely used to select good quality oocytes and embryos ([@bib33]; [@bib15]). To determine the viability and quality of oocyte, demarcation of membrane, perivitelline space, zona pellucida fracture, and cytoplasmic distribution were firstly needed to be checked before conducting the next step of experiment associated with assisted reproductive technology ([@bib34]; [@bib4]). However, the result of morphological assessment does not reflect always to fertilization rates and oocyte/embryo quality after conducting assisted reproductive technology ([@bib10]; [@bib5]; [@bib19]). Previous study showed that high survival rates by morphological inspection did not reflect high quality of oocyte/embryo and developmental competence ([@bib19]).

On the other hand, the FDA assay has been widely applied to determine the viability and quality of embryos ([@bib26]; [@bib28]) and oocytes ([@bib12]; [@bib19]). Because many lipid droplets were in cytoplasm of pig and cattle oocytes, the oocytes were not visible inside by microscope ([@bib22]). Therefore, the FDA assay to determine survival rates and to compare the difference with survival rates by morphological inspection of post-warming pig oocytes.

In the present study, the survival rate of the post-worming oocytes was different between morphological inspection and FDA assay. Although high rate of the vitrified oocytes looked like survive (83.7% to 91.6%) by morphological inspection, the survive rate of the oocytes was decreased (35.1% to 44.2%) by FDA assay. It can be postulated that the morphological inspection was not sufficient to assess viability, at least in the post-warming pig oocyte. To improve the accuracy of FDA assay result, it was subdivided into 4 classifications of strong, intermediate, weak, and none green fluorescence as shown in [Fig. 1](#f1){ref-type="fig"}. As shown [Table 1](#t1){ref-type="table"}, the post-warming pig oocytes vitrified by conventional vitrification protocol showed significantly (*p*\<0.05) decreased numbers of alive oocytes compared to the Fresh Control group like our previous study ([@bib19]). It could be understood that the decreased survival rates were caused by subdivided categorization of alive and dead oocytes. And this result could be indicated that the post-warming oocytes were well divided into alive and dead because only the oocyte having higher enzymatic activity (activation of fluorescence) and cell-membrane integrity (retention of fluorescent) can be detected strong and intermediate green fluorescence. In the present study, the increased number of weak fluorescence in the post-warming oocytes could be indicated that the oocytes lost enzymatic activity and cell-membrane integrity during vitrification procedures.

To overcome cryoinjuries occurred by vitrification procedures, many kinds of attempts have been applied directly or indirectly to the oocyte and embryo in many species ([@bib17]; [@bib7]; [@bib19]). In the present study, it was focused on the physical damages of the oocytes during vitrification procedures. It is well known that the vitrification procedures could affect cytoskeletal damage such microtubule dysfunction, spindle disorder, and mitochondrial function ([@bib16]; [@bib2]; [@bib3]). In the present study, we also tried to determine the appropriate timing for CB treatment either before or after vitrification procedure. Based on our results, the optimal timing of CB treatment was immediately after warming during recovery culture. The CB treatment before vitrification showed adverse effect on the survival rates of the post-warming oocytes similar with previous study ([@bib25]). We concluded that this phenomenon might be related to shrinkage during vitrification procedure. The oocytes vitrified by CB might be shrunk easier than untreated oocyte because of its softened cytoskeletal followed by more difficult to swell up during warming.

In conclusion, the application of subdividing method is a very delicated method to determine the viability of post-warming pig oocyte. Also, the increased survival rates of post-warming pig oocyte treated with Vitri-CB method are firstly described here. The main finding is that short-term (30 min) treatment of the CB during recovery culture could be helpful to refresh the post-warming pig oocyte resulting improved survival rates.
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